Document Detail


Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.
MedLine Citation:
PMID:  19808296     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Ventilatory efficiency, right ventricular (RV) function, and secondary pulmonary hypertension are each prognostic indicators in patients with heart failure due to left ventricular systolic dysfunction, but the relationships among these variables have not been comprehensively investigated. In this study, we hypothesized that inefficient ventilation during exercise, as defined by an abnormally steep relationship between ventilation and carbon dioxide output (Ve/Vco(2) slope), may be a marker of secondary pulmonary hypertension and RV dysfunction in heart failure.
METHODS AND RESULTS: A cohort of patients with systolic heart failure (mean+/-SD age, 58+/-13 years; left ventricular ejection fraction, 0.27+/-0.05; peak oxygen uptake, 11.2+/-3.2 mL kg(-1) min(-1)) underwent incremental cardiopulmonary exercise testing with simultaneous hemodynamic monitoring and first-pass radionuclide ventriculography before and after 12 weeks of treatment with sildenafil, a selective pulmonary vasodilator, or placebo. Ve/Vco(2) slope was positively related to rest and exercise pulmonary vascular resistance (R=0.39 and R=0.60, respectively) and rest pulmonary capillary wedge pressure (R=0.49, P<0.005 for all) and weakly indirectly related to peak exercise RV ejection fraction (R=-0.29, P=0.03). Over the 12-week study period, Ve/Vco(2) slope fell 8+/-3% (P=0.02) with sildenafil and was unchanged with placebo. Changes in Ve/Vco(2) slope correlated with changes in exercise pulmonary vascular resistance (R=0.69, P<0.001) and rest and exercise RV ejection fraction (R=-0.58 and -0.40, respectively, both P<0.05).
CONCLUSIONS: In patients with systolic heart failure and secondary pulmonary hypertension, ventilatory efficiency is closely related to RV function and pulmonary vascular tone during exercise.
Authors:
Gregory D Lewis; Ravi V Shah; Paul P Pappagianopolas; David M Systrom; Marc J Semigran
Related Documents :
9029896 - Pulmonary capacity in lung cancer patients prior to lung resection--comparison of the u...
16972146 - Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of...
3984866 - Response of the right ventricle to exercise in isolated mitral stenosis.
10430716 - Inhaled nitric oxide and vasoconstrictors in acute respiratory distress syndrome.
9843736 - Endurance training changes in lipolytic responsiveness of obese adipose tissue.
3193866 - Wheelchair racing: effects of rim diameter and speed on physiology and technique.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Circulation. Heart failure     Volume:  1     ISSN:  1941-3297     ISO Abbreviation:  Circ Heart Fail     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2009-10-07     Completed Date:  2009-11-10     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  101479941     Medline TA:  Circ Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  227-33     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carbon Dioxide
Cohort Studies
Double-Blind Method
Exercise Test
Female
Heart Failure / complications,  diagnosis,  physiopathology*
Hemodynamics
Humans
Hypertension, Pulmonary / diagnosis,  drug therapy,  etiology,  physiopathology*
Male
Middle Aged
Muscle Tonus*
Muscle, Smooth, Vascular / physiopathology*
Piperazines / therapeutic use
Pulmonary Circulation*
Purines / therapeutic use
Respiration*
Sulfones / therapeutic use
Vascular Resistance
Vasodilator Agents / therapeutic use
Ventricular Function, Right*
Ventriculography, First-Pass
Grant Support
ID/Acronym/Agency:
HL 04021/HL/NHLBI NIH HHS; HL 091106/HL/NHLBI NIH HHS; K23 HL091106/HL/NHLBI NIH HHS; K23 HL091106-01A1/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Piperazines; 0/Purines; 0/Sulfones; 0/Vasodilator Agents; 142M471B3J/Carbon Dioxide; 3M7OB98Y7H/sildenafil
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Absence of exercise capacity improvement after exercise training program: a strong prognostic factor...
Next Document:  Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: im...